Table 2: Angiographic and laboratory measurements of study groups.
| No Reflow | Normal Reflow | p | |
| Na (mmol/L) | 137.99 ± 2.55 | 137.26 ± 2.58 | 0.06 |
| K (mmol/L) | 4.10 ± 0.43 | 4.29 ± 0.50 | 0.09 |
| Creatinine (mg/dl) | 0.9 (0.6-1.8) | 0.9 (0.5-1.8) | 0.49 |
| Serum glucose (mg/dl) | 125 (78-300) | 123 (80-367) | 0.79 |
| Troponin-T (ng/ml) | 0.2 (0.01-10.20) | 0.1 (0.01-9.6) | 0.04 |
| Creatine Kinase-Myocardial Band (U/L) | 12 (2-137) | 9.8 (2-76) | 0.34 |
| Triglyceride (mg/dl) | 175 (100-474) | 167.5 (102-349) | 0.63 |
| Total cholesterol (mg/dl) | 178.66 ± 49.38 | 179.96 ± 53.85 | 0.34 |
| Low density lipoprotein (mg/dl) | 107.07 ± 41.15 | 115.22 ± 49.09 | 1.00 |
| High density lipoprotein (mg/dl) | 41.68 ± 20.64 | 36.82 ± 8.03 | 0.15 |
| White blood cell count (103/mm3) | 10.93 ± 3.14 | 10.58 ± 3.16 | 0.49 |
| Hemoglobin (g/dL) | 14.27 ± 1.86 | 13.44 ± 1.99 | 0.008 |
| Hematocrit (%) | 42.43 ± 5.57 | 40.21 ± 5.85 | 0.016 |
| Lymphocyte (103/mm3) | 2.4 (0.4-16) | 2.55 (1.1-13.4) | 0.37 |
| Neutrophyle (103/mm3) | 7.33 ± 3.26 | 6.96 ± 3.11 | 0.45 |
| Platelet count (103/mm3) | 255.12 ± 54.00 | 233.96 ± 58.52 | 0.19 |
| NLR | 3 (0.3-16.5) | 2.30 (0.01-12.5) | 0.02 |
| PLR | 108.6 (14.6-511.3) | 91.7 (17.2-225.3) | 0.01 |
| Mean platelet volume (fL) | 7.82 ± 1.57 | 7.05 ± 1.76 | 0.02 |
| Platelet distribution width (%) | 19.82 ± 1.84 | 19.17 ± 1.97 | 0.03 |
| Stent diameter (mm) | 3.06 ± 0.36 | 2.92 ± 0.30 | 0.01 |
| Stent lenght (mm) | 25.00 ± 7.62 | 20.89 ± 7.00 | 0.001 |
| Syntax score | 23.26 ± 5.38 | 19.05 ± 5.65 | 0.00001 |
| Culprit lesion | |||
| Left anterior descending | 46 (53) | 55 (32) | 0.36 |
| Left circumflex | 35 (41) | 20 (12) | 0.73 |
| Right Coronary Artery | 18 (21) | 24 (14) | 0.92 |
| One-vessel | 7 (9) | 3 (2) | 0.12 |
| Two-vessel | 40 (47) | 55 (32) | 0.63 |
| Three-vessel | 51 (59) | 41 (24) | 0.79 |
NLR: Neutrophil-lymphocyte ratio; PLR: Platelet-lymphocyte ratio.